(Q36180465)

English

Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC. (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

liver cirrhosis

0 references

1 reference

based on heuristic

inferred from title

autoimmune hepatitis

1 reference

based on heuristic

inferred from title

author name string

Andreas Geier

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Carsten Gartung

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Christoph G Dietrich

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Hermann E Wasmuth

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Patrick Reinartz

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Siegfried Matern

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

World Journal of Gastroenterology

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

12

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

2681-2685

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Autoantibodies and autoantigens in autoimmune hepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612031

1 October 2017

Current and novel immunosuppressive therapy for autoimmune hepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612031

1 October 2017

Autoimmune hepatitis: clinical challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612031

1 October 2017

Autoimmune hepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612031

1 October 2017

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612031

1 October 2017

Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612031

1 October 2017

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612031

1 October 2017

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612031

1 October 2017

A non-invasive method for evaluating cirrhotic portal hypertension by administration of 99mTc-MIBI per rectum.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612031

2 July 2018

Oral budesonide for treatment of autoimmune chronic active hepatitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612031

2 July 2018

Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612031

2 July 2018

Hepatocellular carcinoma complicating HCV-negative autoimmune hepatitis without corticosteroid therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612031

23 September 2018

Natural course of portal hemodynamics in patients with chronic liver diseases, evaluated by per-rectal portal scintigraphy with Tc-99m pertechnetate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612031

23 September 2018

Autoimmune Hepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612031

23 September 2018

Hepatocellular carcinoma complicating autoimmune hepatitis: Role of hepatitis C virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612031

23 September 2018

Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/14669312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma in corticosteroid-treated severe autoimmune chronic active hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14669312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/14669312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meeting report: International Autoimmune Hepatitis Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14669312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical usefulness of evaluation of portal circulation by per rectal portal scintigraphy with technetium-99m pertechnetate

1 reference

https://pubmed.ncbi.nlm.nih.gov/14669312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A cortisol suppression dose-response comparison of budesonide in controlled ileal release capsules with prednisolone

1 reference

https://pubmed.ncbi.nlm.nih.gov/14669312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/14669312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Per-rectal portal scintigraphy with technetium-99m pertechnetate for the early diagnosis of cirrhosis in patients with chronic hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14669312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Portal circulation by technetium-99m pertechnetate per-rectal portal scintigraphy

1 reference

https://pubmed.ncbi.nlm.nih.gov/14669312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral budesonide in the treatment of primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14669312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14669312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial of prednisone and azathioprine in active chronic hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14669312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug therapy in the management of type 1 autoimmune hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14669312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of autoimmune hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14669312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3748/WJG.V9.I12.2681

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36180465&oldid=2050034227"